Clinical Trial Update: Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment [Phase 1]

View source ↗

Summary

Aadi Bioscience is conducting a Phase 1 dose-escalation study to assess the safety and pharmacokinetics of Nab-Sirolimus in patients with locally advanced or me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• nab-sirolimus (sirolimus (nanoparticle albumin-bound formulation))

Snippet

Sponsor: Aadi Bioscience, Inc. | Conditions: Tumor, Solid, Tumor | Phase 1 | Status: RECRUITING